Welcome to SLAS 2023

Drug discovery is a long journey with many uncertainties and pitfalls.

Partnering with a science-driven CRO, offering a wide range of solutions from target identification to the patient, can effectively overcome these challenges.

NUVISAN provides end-to-end solutions from target identification to pre-clinical candidates, including high throughput screening with a 3 million-compound library, lead optimization, pharmacology, and translational research.

In addition to these services we also offer drug metabolism & pharmacokinetics as well as the conduct of GLP toxicology studies. All of these services come together at our Berlin facility, in the heart of Europe.

Watch Video